DaVita Inc. (DVA)
| Market Cap | 8.51B |
| Revenue (ttm) | 11.63B |
| Net Income (ttm) | 834.16M |
| Shares Out | 91.30M |
| EPS (ttm) | 8.16 |
| PE Ratio | 11.42 |
| Forward PE | 11.61 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 253,605 |
| Open | 92.20 |
| Previous Close | 92.34 |
| Day's Range | 92.18 - 93.30 |
| 52-Week Range | 74.97 - 133.88 |
| Beta | 1.17 |
| Analysts | Sell |
| Price Target | 109.52 (+17.5%) |
| Earnings Date | Aug 1, 2022 |
About DVA
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides ... [Read more...]
Financial Performance
In 2021, DaVita's revenue was $11.62 billion, an increase of 0.59% compared to the previous year's $11.55 billion. Earnings were $978.45 million, an increase of 26.47%.
Financial StatementsAnalyst Forecast
According to 16 analysts, the average rating for DVA stock is "Sell." The 12-month stock price forecast is 109.52, which is an increase of 17.51% from the latest price.
News
Down 26%, Is This Buffett Stock a Buy?
Warren Buffett loves to own cash-generating "toll bridge" companies. DaVita qualifies on both counts.
DaVita (DVA) Beats on Q2 Earnings, Reiterates FY22 EPS View
DaVita (DVA) records an overall solid Q2 performance owing to strength in its Other segment's revenues and uptick in total U.S. dialysis treatments.
DaVita HealthCare (DVA) Tops Q2 Earnings Estimates
DaVita HealthCare (DVA) delivered earnings and revenue surprises of 9% and 0.27%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
DaVita Inc. 2nd Quarter 2022 Results
DENVER , Aug. 1, 2022 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended June 30, 2022. "We are living in a dynamic time with a sustained global pand...
3 No-Brainer Warren Buffett Stocks That Will Undeniably Profit from the Bear Market
These unstoppable companies can succeed in pretty much any economic condition.
DaVita (DVA) to Report Q2 Earnings: What's in the Offing?
Supply constraints, along with inflationary pressures, is likely to have weighed on DaVita's (DVA) second quarter's top line.
American Diabetes Association Focuses on Prevention of Kidney Disease through Collaboration with DaVita
American Diabetes Association and DaVita launch a digital experience with resources for preventing and managing diabetes-related kidney complications ARLINGTON, Va. and DENVER , July 25, 2022 /PRNewswir...
3 Reasons to Retain DaVita (DVA) Stock in Your Portfolio
Investors remain optimistic about DaVita (DVA) due to strength in its DaVita Kidney Care.
DaVita Inc. Schedules 2nd Quarter 2022 Investor Conference Call
DENVER , July 18, 2022 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Monday, August 1, 2022, at 5:00 p.m. ...
5 Undervalued Predictable Health Care Stocks
U.S. market indexes kicked off the week lower as investors prepare for the start of second-quarter earnings season.
2 Potential Berkshire Acquisitions
Something I have been thinking about recently is the possibility of Berkshire Hathaway ( BRK.A , Financial) ( BRK.B , Financial) and Warren Buffett (Trades, Portfolio) making an offer for a company that...
3 Stocks Warren Buffett Owns the Biggest Percentage Stakes In (Hint: Apple Isn't 1 of Them)
Based on how big a slice of the pie is owned, these could be viewed as Warren Buffett's favorite stocks.
DaVita HealthCare (DVA) Surges 6%: Is This an Indication of Further Gains?
DaVita HealthCare (DVA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down ...
Rockwell Medical Provides Corporate and Clinical Update
- Closes $7.5 Million Second Tranche Investment from DaVita - $30 Million in Total Capital Raised This Quarter - Receives Additional Feedback from FDA on its IND Application WIXOM, Mich. , June 22, 202...
DaVita Inc. Schedules Special Investor Conference Call
DENVER , June 22, 2022 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today it will hold a special conference call with investors on Thursday, June 23, 2022, at 8:45 a.m. Eastern Time.
U.S. Supreme Court rules against DaVita over dialysis coverage
The U.S. Supreme Court on Tuesday rejected kidney dialysis provider DaVita Inc's claims that an Ohio hospital's employee health plan discriminates against patients with end-stage renal disease by reimbu...
Here's Why You Should Hold on to DaVita (DVA) Stock For Now
Investors remain optimistic about DaVita (DVA) due to strength in its DaVita Kidney Care and impressive overseas growth.
3 Stocks to Watch From a Buoyant Outpatient Home Health Industry
Despite the COVID-19 pandemic-induced challenges, rising dependence on telehealth and AI's dominant role are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, RDNT and US...
Medtronic, DaVita To Jointly Form Kidney Health-Focused Company
Medtronic plc (NYSE: MDT) and DaVita Inc (NYSE: DVA) intend to form a new, independent kidney care-focused medical device company (NewCo). NewCo will focus on developing a broad suite of novel kidney ca...
Medtronic and DaVita announce new kidney health technology company
Companies join forces to accelerate kidney care device innovation and improve patient outcomes DUBLIN and DENVER, May 26, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT) and DaVita Inc. (NYSE:DVA) today a...
Reasons to Retain DaVita (DVA) Stock in Your Portfolio For Now
Investors remain optimistic about DaVita (DVA) due to strength in its DaVita Kidney Care and impressive overseas growth.
Dosis Announces Nationwide Precision Dosing Implementation with DaVita
SAN FRANCISCO--(BUSINESS WIRE)--Dosis, a market leader in artificial intelligence-powered precision dosing, announced today the implementation of its flagship personalized dosing product at DaVita (NYSE...
DaVita Honors Extraordinary Nurses with DAISY Awards
Recognizes nurses who make an exceptional difference in care delivery. DENVER , May 10, 2022 /PRNewswire/ -- DaVita today announced that 56 of its nephrology nurses were honored with the DAISY Award® f...